Zofran Birth Defect Lawsuits
The dangerous drug attorneys at Bernstein Liebhard LLP are advising their clients to file individual lawsuits against Zofran manufacturer GlaxoSmithKline instead of class action lawsuits. When lawsuits are joined in a class action, the damages recovered are evenly distributed across the “class” or entire group of plaintiffs, no matter how serious or severe the injuries of the individuals in the class. Any money you have spent on medical bills or lost if you had to take off work is not considered and may not be recovered if you file in class action. Damages awarded in an individual suit generally take into consideration all injuries suffered, including financial injury. Because the side effects of the drug Zofran may differ per individual, Zofran injuries may vary greatly between plaintiffs, making an individual Zofran injury lawsuit more advisable.
Women who have taken Zofran to treat nausea and vomiting during their first trimester of pregnancy and given birth to a child with a heart defect, cleft lip, skeletal defect, or club foot or other birth defect may be eligible to file a Zofran lawsuit against the manufacturer for allegedly failing to properly warn physicians and their patients about these and other complications associated with use of Zofran.
Zofran was approved by the U.S. Food and Drug Administration in 1991 for the treatment of nausea and vomiting following surgery and cancer treatments. However, the drug is increasingly being used off-label to treat nausea and vomiting in pregnant women (NVP). Zofran has been associated with an increased risk of birth defects when taken by mothers in their first trimester of pregnancy, a critical phase in fetal developments and when morning sickness is most common.
Why Choose Us?
Since 1993 our firm has handled hundreds of cases on behalf of injured consumers and shareholders. We’ve successfully recovered over $3 billion on behalf of our clients.
Over 30 Years Experience
Named by The National Law Journal as one of the top plaintiff’s litigation firms in the US for the past 12 years, our firm and attorneys are among the most qualified in their respective fields.
No Fees Unless You Recover
We accept Zofran cases on a contingency fee basis. This means if we do not obtain a verdict or settlement you owe us nothing. If we do make a recovery, we receive a fraction of the total sum.
Side Effects of the Anti-Nausea Drug Zofran
Zofran, brand name of the drug ondansetron a 5-HT3 receptor antagonist, entered the U.S. market in 1991. The drug works by affecting serotonin levels in the brain. Side effects listed on the label of the drug include constipation or diarrhea, drowsiness, fatigue, and headache. More serious side effects that may indicate an allergic reaction include fever, chills, hives, rash, swelling of the tongue, lips, face, or throat, and breathing difficulties.
However, the medication has been linked to far more serious side effects when used during pregnancy. Women who used Zofran during the first stages of pregnancy may be eligible to file a birth defect lawsuit against Zofran maker GlaxoSmithKline.
Birth defects that may be associated with Zofran include:
Victims of Zofran complications may be entitled to significant damages, including compensation for:
Research Suggests Increased Risk of Zofran Birth Defects
In February 2013, researchers in Denmark conducted a small study where a sampling of data was collected of pregnant mothers and their babies and analyzed. The study reviewed data of about 2,000 patients over a seven year time span. This study, published in The New England Journal of Medicine, showed no association between the use of Zofran and birth defects.
In August of that same year however, researchers in Denmark presented the results of a study that analyzed the data of more than 900,000 patients over a 13 year time span to the International Society of Pharmacoepidemiology. The results of this study showed that babies born to women taking Zofran or the generic version of ondansetron during pregnancy had a 30 percent greater risk of “major congenital malformation” than babies born to mothers who did not take the drug.
In December 2014, researchers published the results of a study in the American Journal of Obstetrics & Gynecology that showed data suggesting an increased risk of birth defects in babies born to mother who use Zofran. In this study, author Dr. Gideon Koren writes that more than 110,000 prescription are written every month to pregnant women in U.S exposing more than one million babies each year to the potential side effects of Zofran.
Filinga Zofran Birth Defect Lawsuit
If you or your loved one used Zofran during pregnancy and your baby was born with birth defects, you may be entitled to compensation for the injuries you and your baby have suffered, as well as for medical expenses and wages lost because of the side effects of Zofran. If you want to learn more about filing a Zofran lawsuit, contact an attorney at Bernstein Liebhard now at 1-844-4-ZOFRAN.
Frequently Asked Questions
Yes, if you believe you were injured from Zofran exposure while you were in the womb, you should call our attorneys for a free case evaluation. People across the country are learning about the possible links between Zofran use in pregnancy and the increased risks of serious birth defects.
Yes, the U.S. Department of Justice announced that Zofran manufacturer GlaxoSmithKline resolved charged made by the government that the drug maker illegally marketing Zofran and several other drugs, including that the company promoted Zofran as an off-label therapy for severe morning sickness. GlaxoSmithKline agreed to pay $3 billion to settle these charges.
We don’t charge our Zofran birth defects clients for the work we do on their behalf, unless your case results in financial recovery. If your case is not successful, you will not owe the attorneys at Bernstein Liebhard LLP anything. If your case is settled or the court makes judgement on your behalf, our fees will be taken out of the recovery. Our retainer fees are fully detailed in the agreement you sign, so there are no surprises.